Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $161.1800 (-0.25%) ($160.6450 - $162.2000) on Mon. Apr. 17, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.03% (three month average) | RSI | 72 | Latest Price | $161.1800(-0.25%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV advances 1.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IBB(16%) XBI(14%) XOP(14%) XLE(12%) IWC(11%) | Factors Impacting ABBV price | ABBV will decline at least -0.515% in a week (0% probabilities). XLC(-23%) XLK(-12%) VUG(-12%) QQQ(-12%) IPO(-12%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.515% (StdDev 1.03%) | Hourly BBV | -0.8 () | Intraday Trend | -0.5% | | | |
|
5 Day Moving Average | $161.84(-0.41%) | 10 Day Moving Average | $161.34(-0.1%) | 20 Day Moving Average | $159.34(1.15%) | To recent high | -0.9% | To recent low | 11.5% | Market Cap | $284.367b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |